![Dimethyl Fumarate | CAS:624-49-7 | Nrf2 pathway activator; neuroprotective | High Purity | Manufacturer BioCrick Dimethyl Fumarate | CAS:624-49-7 | Nrf2 pathway activator; neuroprotective | High Purity | Manufacturer BioCrick](https://www.biocrick.com/media/images/struct/BCC4776.png)
Dimethyl Fumarate | CAS:624-49-7 | Nrf2 pathway activator; neuroprotective | High Purity | Manufacturer BioCrick
![147245-92-9 CAS MSDS (Glatiramer acetate) Melting Point Boiling Point Density CAS Chemical Properties 147245-92-9 CAS MSDS (Glatiramer acetate) Melting Point Boiling Point Density CAS Chemical Properties](https://www.chemicalbook.com/CAS/20180808/GIF/147245-92-9.gif)
147245-92-9 CAS MSDS (Glatiramer acetate) Melting Point Boiling Point Density CAS Chemical Properties
![Glatiramer acetate in primary progressive multiple sclerosis: Results of a multinational, multicenter, double‐blind, placebo‐controlled trial - Wolinsky - 2007 - Annals of Neurology - Wiley Online Library Glatiramer acetate in primary progressive multiple sclerosis: Results of a multinational, multicenter, double‐blind, placebo‐controlled trial - Wolinsky - 2007 - Annals of Neurology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/73dd2697-954c-4d19-8272-11db35d03e9f/mfig001.jpg)
Glatiramer acetate in primary progressive multiple sclerosis: Results of a multinational, multicenter, double‐blind, placebo‐controlled trial - Wolinsky - 2007 - Annals of Neurology - Wiley Online Library
![US 7495072 B2 - Process for preparation of mixtures of polypeptides using purified hydrobromic acid | Full-text US 7495072 B2 - Process for preparation of mixtures of polypeptides using purified hydrobromic acid | Full-text](https://s3-us-west-2.amazonaws.com/lens-resource/patent/US/B2/7495/7495072/image/page/10pc/00000003.png)
US 7495072 B2 - Process for preparation of mixtures of polypeptides using purified hydrobromic acid | Full-text
![Frontiers | Alemtuzumab in a Large Real-Life Cohort: Interim Baseline Data of the TREAT-MS Study | Neurology Frontiers | Alemtuzumab in a Large Real-Life Cohort: Interim Baseline Data of the TREAT-MS Study | Neurology](https://www.frontiersin.org/files/Articles/620758/fneur-12-620758-HTML-r1/image_m/fneur-12-620758-t003.jpg)
Frontiers | Alemtuzumab in a Large Real-Life Cohort: Interim Baseline Data of the TREAT-MS Study | Neurology
![79517-01-4 | Octreotide Acetate | D-Phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-L-cysteinamide Cyclic (2-7)-Disulfide Acetate; SMS 201-995ac; Sandostatin; Sandostatin LAR ... 79517-01-4 | Octreotide Acetate | D-Phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-L-cysteinamide Cyclic (2-7)-Disulfide Acetate; SMS 201-995ac; Sandostatin; Sandostatin LAR ...](https://www.trc-canada.com/prod-img/O239950.png)
79517-01-4 | Octreotide Acetate | D-Phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-L-cysteinamide Cyclic (2-7)-Disulfide Acetate; SMS 201-995ac; Sandostatin; Sandostatin LAR ...
![US8859489B2 - Water-mediated control of depolymerization step of glatiramer acetate synthesis - Google Patents US8859489B2 - Water-mediated control of depolymerization step of glatiramer acetate synthesis - Google Patents](https://patentimages.storage.googleapis.com/c0/ae/ad/8bd5c808b83ff1/US08859489-20141014-D00001.png)
US8859489B2 - Water-mediated control of depolymerization step of glatiramer acetate synthesis - Google Patents
![US8859489B2 - Water-mediated control of depolymerization step of glatiramer acetate synthesis - Google Patents US8859489B2 - Water-mediated control of depolymerization step of glatiramer acetate synthesis - Google Patents](https://patentimages.storage.googleapis.com/f4/55/60/d13c5f1c7c426c/US08859489-20141014-D00002.png)
US8859489B2 - Water-mediated control of depolymerization step of glatiramer acetate synthesis - Google Patents
![Recombinant Human Tumor necrosis factor receptor superfamily member 5(CD40),partial (Active) - Cusabio Recombinant Human Tumor necrosis factor receptor superfamily member 5(CD40),partial (Active) - Cusabio](https://www.cusabio.com/uploadfile/protein/1/CSB-AP005171HU.jpg)
Recombinant Human Tumor necrosis factor receptor superfamily member 5(CD40),partial (Active) - Cusabio
![MSDS 3D data transfer to the TREAT DATABASE server via internet-based... | Download Scientific Diagram MSDS 3D data transfer to the TREAT DATABASE server via internet-based... | Download Scientific Diagram](https://www.researchgate.net/profile/Tjalf-Ziemssen/publication/305401905/figure/fig3/AS:385421386240002@1468903027559/MSDS-3D-data-transfer-to-the-TREAT-DATABASE-server-via-internet-based-or-locally_Q640.jpg)
MSDS 3D data transfer to the TREAT DATABASE server via internet-based... | Download Scientific Diagram
![Achieving patient engagement in multiple sclerosis: A perspective from the multiple sclerosis in the 21st Century Steering Group - Multiple Sclerosis and Related Disorders Achieving patient engagement in multiple sclerosis: A perspective from the multiple sclerosis in the 21st Century Steering Group - Multiple Sclerosis and Related Disorders](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2031531498/2048646268/gr1.jpg)